Shuttle Pharmaceuticals Holdings Inc (SHPH)

$4.18 -0.71 (-14.52%)
Market Cap 2.86M
Revenue (ttm) 0.00
Net Income (ttm) -11.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 127,800
Avg Vol 171,663
Day's Range N/A - N/A
Shares Out 5.85M
Stochastic %K 22%
Beta 0.18
Analysts Strong Buy
Price Target N/A

Company Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 403 4212
Address:
401 Professional Drive, Suite 260, Gaithersburg, United States
TwongStocks
TwongStocks Jun. 11 at 8:39 PM
Today's reverse split results $GMM 1 for 50 Previous close $0.0587, $2.935 split-adjusted Today's high $3.40 (premarket) Today's close $2.88 🔴Down 1.87% $SHPH 1 for 10 Previous close $0.4890, $4.89 split-adjusted Today's high $4.88 (premarket) Today's close $4.18 🔴Down 14.52%
0 · Reply
lucabrix
lucabrix Jun. 11 at 3:42 PM
$SHPH sometimes investments turn into charity given away - amen
0 · Reply
CantAffordMe
CantAffordMe Jun. 11 at 12:47 PM
$SHPH I hope you like dogshit because that's all this scam is.
0 · Reply
TwongStocks
TwongStocks Jun. 11 at 12:30 PM
$GMM $SHPH Both with reverse splits today, full details in the quoted post. Trading will resume at 9:00am ET, with the RS in effect.
0 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Jun. 11 at 7:31 AM
$SHPH * Shuttle Pharmaceuticals Holdings (SHPH) has a 1-for-10 reverse stock split taking effect today, Thursday, June 11, 2026. Prior to the split, SHPH had approximately 5.80 million shares in the public float out of 6,371,075 total issued and outstanding shares. ​Applying the strict 1-for-10 math, the estimated post-split float is: ​Estimated New Float: \approx 580,000 shares.
0 · Reply
TwongStocks
TwongStocks Jun. 10 at 8:16 PM
Two NASDAQ stocks with reverse splits scheduled on Thursday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Thursday morning. $GMM 1 for 50. Will reduce outstanding Class A shares from approx 89.58m to approx 1.79m. $SHPH 1 for 10. Will reduce outstanding shares from approx 6.37m to approx 637k.
2 · Reply
bionicman1969
bionicman1969 Jun. 10 at 5:04 AM
$SHPH sounds like a good pump but I will avoid. Popcorn.
0 · Reply
TwongStocks
TwongStocks Jun. 9 at 7:04 PM
$SHPH Equity Corporate Actions Alert #2026 - 394 Information Regarding the Reverse Stock Split and CUSIP Number Change for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-394 Shuttle Pharmaceuticals Holdings, Inc. (SHPH) will effect a one-for-ten (1-10) reverse split of its Common Stock. The reverse stock split will become effective on Thursday, June 11, 2026. In conjunction with the reverse split, the CUSIP number will change to 825693500.
0 · Reply
newsfile_corp
newsfile_corp Jun. 9 at 12:30 PM
https://nfne.ws/300646 $SHPH @shuttlepharma #Chemicals #Pharmaceutical #Medical #Pharmaceuticals #NASDAQ #Investing
0 · Reply
crabhunter
crabhunter Jun. 8 at 5:33 PM
$HKIT $SHPH Biding my time Waiting for a $INHD moment. Or Maybe it’s an $ HKIT moment
0 · Reply
Latest News on SHPH
Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

2026-06-10T23:50:59.000Z - 1 day ago

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time

Jun 9, 2026, 8:30 AM EDT - 2 days ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 11, 2026, at 12:01 a.m., Eastern Time

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

May 14, 2026, 4:05 PM EDT - 4 weeks ago

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

May 7, 2026, 2:02 PM EDT - 5 weeks ago

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

May 1, 2026, 8:41 AM EDT - 5 weeks ago

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

Apr 30, 2026, 4:05 PM EDT - 6 weeks ago

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 27, 2026, 8:00 AM EDT - 2 months ago

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Mar 26, 2026, 4:05 PM EDT - 2 months ago

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public Offering

Mar 12, 2026, 8:30 AM EDT - 3 months ago

E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals' $3.5 Million Public Offering

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Mar 6, 2026, 8:00 AM EST - 3 months ago

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Jan 13, 2026, 4:00 PM EST - 5 months ago

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Shuttle Pharmaceuticals Acquires AI Health Platform

Nov 21, 2025, 9:30 AM EST - 7 months ago

Shuttle Pharmaceuticals Acquires AI Health Platform

Shuttle Pharmaceuticals files to sell 625,156 shares of common stock for holders

2025-11-18T22:05:15.000Z - 7 months ago

Shuttle Pharmaceuticals files to sell 625,156 shares of common stock for holders

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Nov 3, 2025, 7:00 AM EST - 7 months ago

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Oct 22, 2025, 10:00 AM EDT - 8 months ago

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Oct 22, 2025, 7:00 AM EDT - 8 months ago

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Oct 21, 2025, 5:55 PM EDT - 8 months ago

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

Oct 21, 2025, 4:05 PM EDT - 8 months ago

Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform

Shuttle Pharmaceuticals announces extension of LOI with Molecule.ai

2025-10-10T14:25:15.000Z - 8 months ago

Shuttle Pharmaceuticals announces extension of LOI with Molecule.ai

Shuttle Executes LOI with Molecule.ai

Oct 10, 2025, 10:20 AM EDT - 8 months ago

Shuttle Executes LOI with Molecule.ai

Shuttle Pharmaceuticals to acquire Molecule.ai for $10M

2025-10-09T20:25:12.000Z - 8 months ago

Shuttle Pharmaceuticals to acquire Molecule.ai for $10M

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Oct 9, 2025, 4:15 PM EDT - 8 months ago

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

Aug 14, 2025, 4:05 PM EDT - 10 months ago

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

Shuttle Pharmaceuticals files to sell 1.18M shares of common stock for holders

2025-08-05T10:16:04.000Z - 11 months ago

Shuttle Pharmaceuticals files to sell 1.18M shares of common stock for holders

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Jun 24, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

Jun 20, 2025, 3:55 PM EDT - 1 year ago

Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

2025-06-13T23:50:22.000Z - 1 year ago

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

2025-06-12T16:05:29.000Z - 1 year ago

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

Jun 12, 2025, 12:00 PM EDT - 1 year ago

Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

2025-06-12T12:45:38.000Z - 1 year ago

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

Jun 12, 2025, 8:30 AM EDT - 1 year ago

Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative

Shuttle Pharmaceuticals appoints George Scorsis as chairman

2025-06-04T20:10:45.000Z - 1 year ago

Shuttle Pharmaceuticals appoints George Scorsis as chairman

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Jun 4, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Shuttle Pharma Ropidoxuridine Phase 2 trial nears 50% enrollment

2025-05-15T20:50:26.000Z - 1 year ago

Shuttle Pharma Ropidoxuridine Phase 2 trial nears 50% enrollment

Shuttle Pharma Provides Corporate Update

May 15, 2025, 4:45 PM EDT - 1 year ago

Shuttle Pharma Provides Corporate Update

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

May 8, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Apr 21, 2025, 4:15 PM EDT - 1 year ago

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Shuttle Pharmaceuticals files provisional patent application with USPTO

2025-04-10T20:10:54.000Z - 1 year ago

Shuttle Pharmaceuticals files provisional patent application with USPTO

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Apr 10, 2025, 4:01 PM EDT - 1 year ago

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

Mar 13, 2025, 4:10 PM EDT - 1 year ago

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

Shuttle Pharmaceuticals prices 19.17M shares at 30c per share in public offering

2025-03-12T13:30:38.000Z - 1 year ago

Shuttle Pharmaceuticals prices 19.17M shares at 30c per share in public offering

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

Mar 12, 2025, 9:24 AM EDT - 1 year ago

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO

2025-03-12T10:25:28.000Z - 1 year ago

Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Mar 12, 2025, 6:20 AM EDT - 1 year ago

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

Feb 26, 2025, 10:45 AM EST - 1 year ago

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

Shuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine

2025-01-21T14:15:45.000Z - 1 year ago

Shuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 7, 2025, 9:00 AM EST - 1 year ago

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF

2024-12-19T14:11:32.000Z - 1 year ago

Shuttle Pharmaceuticals enters into sponsored research agreement with UCSF

Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line

2024-11-26T14:06:10.000Z - 1 year ago

Shuttle first patient enrollment, dosing in Phase 2 Ropidoxuridine line

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Nov 26, 2024, 9:00 AM EST - 1 year ago

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Nov 13, 2024, 5:00 PM EST - 1 year ago

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share

2024-10-30T01:10:10.000Z - 1 year ago

Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per share

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 29, 2024, 9:05 PM EDT - 1 year ago

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Oct 28, 2024, 4:05 PM EDT - 1 year ago

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Sep 16, 2024, 9:00 AM EDT - 1 year ago

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Sep 4, 2024, 4:15 PM EDT - 1 year ago

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Aug 26, 2024, 4:10 PM EDT - 1 year ago

Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Aug 14, 2024, 4:10 PM EDT - 1 year ago

Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Jul 19, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

Jun 18, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 22, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

Shuttle Pharma Provides First Quarter 2024 Corporate Update

May 14, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides First Quarter 2024 Corporate Update

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 23, 2024, 4:15 PM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Apr 3, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Mar 22, 2024, 9:00 AM EDT - 2 years ago

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

Mar 5, 2024, 9:00 AM EST - 2 years ago

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

Shuttle Pharma Announces Its Intent to Pursue a Rights Offering

Feb 13, 2024, 8:00 AM EST - 2 years ago

Shuttle Pharma Announces Its Intent to Pursue a Rights Offering

TwongStocks
TwongStocks Jun. 11 at 8:39 PM
Today's reverse split results $GMM 1 for 50 Previous close $0.0587, $2.935 split-adjusted Today's high $3.40 (premarket) Today's close $2.88 🔴Down 1.87% $SHPH 1 for 10 Previous close $0.4890, $4.89 split-adjusted Today's high $4.88 (premarket) Today's close $4.18 🔴Down 14.52%
0 · Reply
lucabrix
lucabrix Jun. 11 at 3:42 PM
$SHPH sometimes investments turn into charity given away - amen
0 · Reply
CantAffordMe
CantAffordMe Jun. 11 at 12:47 PM
$SHPH I hope you like dogshit because that's all this scam is.
0 · Reply
TwongStocks
TwongStocks Jun. 11 at 12:30 PM
$GMM $SHPH Both with reverse splits today, full details in the quoted post. Trading will resume at 9:00am ET, with the RS in effect.
0 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Jun. 11 at 7:31 AM
$SHPH * Shuttle Pharmaceuticals Holdings (SHPH) has a 1-for-10 reverse stock split taking effect today, Thursday, June 11, 2026. Prior to the split, SHPH had approximately 5.80 million shares in the public float out of 6,371,075 total issued and outstanding shares. ​Applying the strict 1-for-10 math, the estimated post-split float is: ​Estimated New Float: \approx 580,000 shares.
0 · Reply
TwongStocks
TwongStocks Jun. 10 at 8:16 PM
Two NASDAQ stocks with reverse splits scheduled on Thursday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Thursday morning. $GMM 1 for 50. Will reduce outstanding Class A shares from approx 89.58m to approx 1.79m. $SHPH 1 for 10. Will reduce outstanding shares from approx 6.37m to approx 637k.
2 · Reply
bionicman1969
bionicman1969 Jun. 10 at 5:04 AM
$SHPH sounds like a good pump but I will avoid. Popcorn.
0 · Reply
TwongStocks
TwongStocks Jun. 9 at 7:04 PM
$SHPH Equity Corporate Actions Alert #2026 - 394 Information Regarding the Reverse Stock Split and CUSIP Number Change for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-394 Shuttle Pharmaceuticals Holdings, Inc. (SHPH) will effect a one-for-ten (1-10) reverse split of its Common Stock. The reverse stock split will become effective on Thursday, June 11, 2026. In conjunction with the reverse split, the CUSIP number will change to 825693500.
0 · Reply
newsfile_corp
newsfile_corp Jun. 9 at 12:30 PM
https://nfne.ws/300646 $SHPH @shuttlepharma #Chemicals #Pharmaceutical #Medical #Pharmaceuticals #NASDAQ #Investing
0 · Reply
crabhunter
crabhunter Jun. 8 at 5:33 PM
$HKIT $SHPH Biding my time Waiting for a $INHD moment. Or Maybe it’s an $ HKIT moment
0 · Reply
crabhunter
crabhunter Jun. 8 at 5:31 PM
$SHPH Biding my time Waiting for a $INHD moment.
0 · Reply
Maxandbear
Maxandbear Jun. 7 at 8:55 AM
$SHPH i sold big disapointment just wait til next pump and dump.
0 · Reply
Giuseppe7
Giuseppe7 Jun. 6 at 1:24 AM
$SHPH what caused all that volume earlir?
0 · Reply
j_joss420
j_joss420 Jun. 6 at 12:17 AM
$SHPH 2 words on the last two days for the recent investors of this toilet bowl. Exit Liquidity. Wonder how long till the RS
0 · Reply
William11171
William11171 Jun. 5 at 11:47 PM
$DSS $SHPH $MBIO pls someone make this shitty ass new market make sense or im personally going to have words with it what the actual fuck has happened to this place truly does no one hold stock anymore?
2 · Reply
topstockalerts
topstockalerts Jun. 5 at 11:23 PM
$SHPH didn’t think it would go this early but here we are
0 · Reply
Shelby375
Shelby375 Jun. 5 at 11:09 PM
$SHPH
0 · Reply
Stocksgoogle
Stocksgoogle Jun. 5 at 10:58 PM
$SHPH any news this is going up a lot.. trade carefully though DYOR GLTA
1 · Reply
CantAffordMe
CantAffordMe Jun. 5 at 2:04 PM
$SHPH when bankruptcy?
0 · Reply
Tyranic
Tyranic Jun. 5 at 12:15 AM
$SHPH Buy warrants. Can still be converted at .45intil July
0 · Reply
luminouslumens
luminouslumens Jun. 4 at 11:44 PM
$SMTK $BGMS $SHPH $INDP A few momentum tickers to keep an eye on premarket tomorrow
0 · Reply
RETAlerts
RETAlerts Jun. 4 at 11:28 PM
📊 Retail Edge — End of Day Recap (6/4) 19 low-float alerts today. 9 ran +15%+ ( our win criteria). 10 didn't. Win rate: 47%. Here's the real board, winners and duds: 🚀 $STI +360% — Gen-ECB space-battery unveil. Alerted 27x as it ran. 🟢 $EDHL +99% — low-float momentum, no news found 🟢 $SHPH +66% — low-float momentum, no news found 🟢 $NEXR +53% — low-float momentum, no news found 🟢 $RMSG +41% — low-float momentum, no news found And the honest part: 10 of 19 didn't follow through. We post the whole tape, not just the green. A "win" = +15% from our first alert. Real-time, paper-tracked. Not financial advice. Algo generated alerts. Check out our bio to get involved. Hope you ended the day green. Happy Trading!
0 · Reply